ArticleJournal of neurology2013
Future MS care: a consensus statement of the MS in the 21st Century Steering Group.
Article in Journal of neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering Group.Neurology and therapy · 2026Article
- Predictors of Ability to Work in Multiple Sclerosis.CPT: pharmacometrics & systems pharmacology · 2025Article
- Consensus quality indicators for monitoring multiple sclerosis.The Lancet regional health. Europe · 2024Review
- Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS.Frontiers in neurology · 2023Article
- Parkinson's Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East.Journal of Parkinson's disease · 2020Article
- Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care.Advances in therapy · 2019Article
- Involvement of miR-126 in autoimmune disorders.Clinical and molecular allergy : CMA · 2018Review
- New insights into the burden and costs of multiple sclerosis in Europe.Multiple sclerosis (Houndmills, Basingstoke, England) · 2017Article
- Remotely engaged: Lessons from remote monitoring in multiple sclerosis.International journal of medical informatics · 2017Article
- Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs.Journal of health psychology · 2016Article
- Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis.European journal of public health · 2015Article
- Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia.Journal of neurology · 2014Review
- Multiple sclerosis imaging: recent advances.Journal of neurology · 2013Review
- Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries.Multiple sclerosis international · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The "MS in the 21st Century" initiative was established with the purpose of (1) defining how multiple sclerosis (MS) treatment and standards of care should look in the 21st century; (2) developing a minimum standard of care across the world; and (3) motivating the broad MS community to align standards of care and challenge the current treatment paradigm. The aim was to develop a consensus statement to reach and influence the broader MS community. An expert steering group from Europe and Canada-consisting of neurologists, patient advocates, a pharmacoepidemiologist/pharmacoeconomist, and representatives from national MS centers-participated in a series of workshop-driven meetings between February 2011 and 2012. After three phases of discussions, the steering group identified that the overall vision for future care of MS should be full access to personalized treatment, with reimbursement, to achieve freedom from disease. They constructed seven overall principles that support this vision: personalized care, patient engagement, commitment to research, regulatory body education and reimbursement issues, new endpoints in clinical trials, more therapy options, and MS centers of excellence. This consensus statement outlines the key aspects of the seven principles that need to be addressed. The "MS in the 21st Century Steering Group" hopes that this consensus statement acts as a call to action for healthcare providers and decision-makers to address simultaneously the overarching principles that will guide patient management in order to improve outcomes for people with MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.